Search Medical Condition
Please enter condition
Please choose location from dropdown

Heart Failure Clinical Trials

A listing of Heart Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (871) clinical trials

Dr. Linda Peterson and Dr. Andrew Coggan are conducting a research study to determine the benefits of beet root juice on exercise performance. There are 2 study visits. Each visit will last about 5 hours. There will be a 6 minute walk, strength testing using the Biodex machine, and an ...

Phase N/A

Since 2002, wearable cardioverter defibrillators (WCD) have been approved for use in the USA and Europe to prevent sudden death due to rapid abnormal rhythms of the heart. In this particular model, more data is collected and additional options are available that may help in the monitoring and treatment of ...

Phase N/A

Nurses at the University of Kentucky are conducting research about heart disease and salt consumption. We are inviting you to join a Family Sodium Watcher Program (FAMSWAP) study that might help people with heart failure reduce the amount of sodium (salt) they consume by participating in a diet along with ...

Phase N/A

The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) conduction and left bundle branch block (LBBB).

Phase

This study is being done to compare the effects of bucindolol hydrochloride (bucindolol) to metoprolol succinate (Toprol-XL) on the recurrence of symptomatic atrial fibrillation/atrial flutter in patients with heart failure who have a specific genotype for the beta-1 adrenergic receptor.

Phase

Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to standard diuretic and comorbidity treatment for heart failure with preserved ejection fraction (HFpEF).

Phase N/A

Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to standard therapy for heart failure with reduced ejection fraction (HFrEF).

Phase N/A

Announcing a new research study of nutritional supplements Specifically, the study will examine whether certain supplements can reduce readmission rates in adults >65 years of age who are hospitalized for the following diagnoses: Heart attack Heart failure COPD Pneumonia

Phase N/A

This study is designed to assess the efficacy, safety and tolerability of ixmyelocel-T compared to placebo (vehicle control) when administered via transendocardial catheter-based injections to patients with end stage heart failure due to IDCM, who have no reasonable revascularization options (either surgical or percutaneous interventional) likely to provide clinical benefit. ...

Phase